Live Breaking News & Updates on Radiology Research

Stay updated with breaking news from Radiology research. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Bayer initiates Phase III studies with investigational contrast agent gadoquatrane

Bayer initiates Phase III studies with investigational contrast agent gadoquatrane
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Konstanze Diefenbach , Michael Forsting , Clarivate Decision Resources Group , University Essen , National Institute Of Biomedical Imaging , Global Head Of Radiology Research Development , Interventional Radiology , Global Head , Radiology Research , Novel Tetrameric , Biomedical Imaging , Magnetic Resonance Imaging , Retrieved June , Imaging Market Guide , Stated Edition , Decision Resources ,

Bayer initiates Phase III studies with investigational contrast agent gadoquatrane

WHIPPANY, N.J. (BUSINESS WIRE) Jun 27, 2023 ....

United States , Konstanze Diefenbach , Michael Forsting , Clarivate Decision Resources Group , Global Head Of Radiology Research Development , National Institute Of Biomedical Imaging , University Essen , Interventional Radiology , Global Head , Radiology Research , Novel Tetrameric , Biomedical Imaging , Magnetic Resonance Imaging , Retrieved June , Imaging Market Guide , Stated Edition , Decision Resources , Business Wire ,

Ultravist Approval Expanded to Include Contrast-Enhanced Mammography

The FDA has approved Ultravist (iopromide) for contrast-enhanced mammography to visualize known or suspected lesions of the breast. ....

Konstanze Diefenbach , Drug Administration , Head Of Radiology Research , Breast Imaging Reporting , Data System , Radiology Research ,

FDA Approves Iopromide Injection for Contrast-Enhanced Mammography

The FDA has approved the first and only iodine-based contrast agent iopromide-300, -370 injection for intra-arterial and intravenous contrast-enhanced mammography. ....

Konstanze Diefenbach , Radiology Research ,

FDA approves Bayer's Ultravist® (iopromide) injection for contrast-enhanced mammography

FDA approves Bayer's Ultravist® (iopromide) injection for contrast-enhanced mammography
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Hannah Perry , Williamf Sensakovic , Kimeyaf Ghaderi , Parisa Lotfi , Tejass Mehta , Marcbi Lobbes , Konstanze Diefenbach , Susang Koman , Maxines Jochelson , Jordana Phillips , World Health Organization , Drug Administration , Head Of Radiology Research , Radiology Research , Magnetic Resonance Imaging , Injection System , Contrast Computed Tomography , Full Prescribing , Intrathecal Use , Kidney Injury , Adverse Reactions , Injection Site Reactions , Pediatric Patients , Cell Crisis , Sickle Cell Disease , Cutaneous Adverse Reactions ,